• Citer

Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)

par Abdou, Yara;Rozenblit, Mariya;Trapani, Dario;Zerdes, Ioannis;Boudreau, Erin;Zhou, Yang;Adam, Virginie;Barrios, Carlos H;Bousrih, Chayma;Branch, Vernal;Carey, Lisa L.A.;Cameron, David A;Chen, Samantha;Chua, Boon B.H.;Davidson, Nancy E;Domchek, Susan S.M.;El-abed, Sarra;El-Ashry, Dorraya;Flowers, Margaret;Foldi, Julia;Garber, Judy Ellen;Goulioti, Theodora;Hodgdon, Christine;Hung, Jessica J.L.C.;Klar, Natalie NJ;Norton, Larry;Parajuli, Ritesh;Piccart-Gebhart, Martine ;Pollastro, Teri;Santa-Maria, Cesar Augusto;Schumacher-Wulf, Eva;Stecklein, Shane S.R.;Thulin, Anna;Tovey, Holly;Winer, Eric;Wolff, Antonio C;Lin, Nancy U;O'Reilly, Séamus
Référence NPJ breast cancer, 12, 1, 69
Publication Publié, 2026

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Early-career investigators face growing challenges: dwindling public funding, limited trial leadership opportunities, systemic mentorship barriers, and widening global disparities. At the 20th Breast International Group (BIG) – NCI National Clinical Trials Network (NCTN) annual meeting, four key themes emerged: funding, mentorship, clinical trials, and translational research. This report outlines recommendations for funding and mentorship. Investment in this area is strategic to ensure continued advances for patients globally.